Sorrento Therapeutics Acquires Clinical Stage Drug Candidate for Treatment of … – PR Newswire (press release)

by admin on October 11, 2013

Sorrento Therapeutics Acquires Clinical Stage Drug Candidate for Treatment of
PR Newswire (press release)
SAN DIEGO, Oct. 10, 2013 /PRNewswire/ — Sorrento Therapeutics, Inc. (OTC QB: SRNE; Sorrento) announced today that it has acquired Sherrington Pharmaceuticals, Inc. (Sherrington), a privately-held company focused on the development of a chronic pain 

and more »

View full post on chronic pain – Google News

Previous post:

Next post: